Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.78 |
| ▸ | GALR3 | O60755 | 1/20 | 0.78 |
| ▸ | NPC1 | O15118 | 6/20 | 0.72 |
| ▸ | NAMPT | P43490 | 5/20 | 0.69 |
| ▸ | TNF | P01375 | 1/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL789622 | 0.89 | RAB9A (0.78) | RAB9AMAPK1GALR3NPC1TNF | |
| SCHEMBL789931 | 0.88 | NAMPT (0.68) | RAB9AMAPK1GALR3NPC1NAMPT | |
| SCHEMBL790020 | 0.88 | RAB9A (0.75) | RAB9AMAPK1GALR3NPC1TNF | |
| SCHEMBL12978054 | 0.87 | RAB9A (0.62) | RAB9AMAPK1GALR3NPC1NAMPT | |
| SCHEMBL790679 | 0.85 | CYP11B1 (0.68) | RAB9AMAPK1GALR3NPC1NAMPT | |
| SCHEMBL791892 | 0.85 | CYP11B1 (0.68) | RAB9AMAPK1GALR3NPC1NAMPT | |
| SCHEMBL789972 | 0.85 | RAB9A (0.62) | RAB9AMAPK1GALR3NPC1TNF | |
| SCHEMBL790138 | 0.84 | RAB9A (0.62) | RAB9AMAPK1GALR3NPC1NAMPT | |
| SCHEMBL12978206 | 0.84 | RAB9A (0.58) | RAB9AMAPK1GALR3NPC1NAMPT | |
| SCHEMBL791160 | 0.83 | CYP11B1 (0.70) | RAB9AMAPK1GALR3NPC1TNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2615917-A2 | PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS III | BASF SE (DE) | 2013-07-24 | — | — | EP | disclosed |
| US-20130180014-A1 | Pyridine Compounds for Controlling Invertebrate Pests III | BASF SE (DE) | 2013-07-11 | — | — | US | disclosed |
| WO-2012034959-A2 | PYRIDINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS III | BASF SE (DE) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130180014-A1 | Pyridine Compounds for Controlling Invertebrate Pests III | CHRM1, CHRM2, GRIN2C | RAB9A 1112/4885MAPK1 1896/4885GALR3 579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.